SEC-sourced researchBeta
HALO
HALOZYME THERAPEUTICS, INC.
Company comparison ↗
Data passport
- CIK
- 0001159036
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 829,253,000.0000 | Feb 17, 2026 |
| December 2024 | 1,015,324,000.0000 | Feb 17, 2026 |
| December 2025 | 1,396,611,000.0000 | Feb 17, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,396,611,000.0000 | 316,889,000.0000 | 651,558,000.0000 | 2,525,323,000.0000 | 2,476,509,000.0000 | Feb 17, 2026 |
| December 2024 | 1,015,324,000.0000 | 444,091,000.0000 | 479,064,000.0000 | 2,063,477,000.0000 | 1,699,656,000.0000 | Feb 17, 2026 |
| December 2023 | 829,253,000.0000 | 281,594,000.0000 | 388,571,000.0000 | — | — | Feb 17, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.4B | December 2025 | Feb 17, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.02B | December 2024 | Feb 17, 2026 | 10-K |
| Net incomeNetIncomeLoss | $316.89M | December 2025 | Feb 17, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $651.56M | December 2025 | Feb 17, 2026 | 10-K |
| Total assetsAssets | $2.53B | December 2025 | Feb 17, 2026 | 10-K |
| Total liabilitiesLiabilities | $2.48B | December 2025 | Feb 17, 2026 | 10-K |
New filings
- 4HALO · HALOZYME THERAPEUTICS, INC.Oct 2, 2026 · Other
- 3HALO · HALOZYME THERAPEUTICS, INC.Oct 2, 2026 · Other
- 4HALO · HALOZYME THERAPEUTICS, INC.Oct 2, 2026 · Other
- 8-KHALO · HALOZYME THERAPEUTICS, INC.Sep 30, 2026 · Current event
- 8-KHALO · HALOZYME THERAPEUTICS, INC.Sep 22, 2026 · Current event
- 8-KHALO · HALOZYME THERAPEUTICS, INC.Sep 18, 2026 · Current event
- 4HALO · HALOZYME THERAPEUTICS, INC.Sep 17, 2026 · Other
- 144HALO · HALOZYME THERAPEUTICS, INC.Sep 16, 2026 · Other
- 8-KHALO · HALOZYME THERAPEUTICS, INC.Sep 16, 2026 · Current event
- 4HALO · HALOZYME THERAPEUTICS, INC.Sep 11, 2026 · Other
- 4HALO · HALOZYME THERAPEUTICS, INC.Sep 2, 2026 · Other
- 10-KHALO · HALOZYME THERAPEUTICS, INC.Feb 17, 2026 · Annual